Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Christenson

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 26, 1982
A routine method for the determination of digoxin in urine by radioimmunoassayR H Christenson, J E Hammond, J H Hull, et al.
Hybridoma|January 16, 1999
Production and characterization of monoclonal antibodies to human carbonic anhydrase IIIH M Azzazy, P J Cummings, D R Ambrozak, et al.
Archives of Pathology & Laboratory Medicine|December 11, 1991
Improving the reliability of total and high-density lipoprotein cholesterol measurements. Four testing strategies compared in a high-risk populationR H Christenson, J R Roeback, T E Watson, et al.
Clinical Chemistry|April 1, 1987
Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxinR H Christenson, S D Studenberg, S Beck-Davis, et al.
Clinical Biochemistry|December 12, 2001
Performance characteristics of a revised cardiac Troponin I assay for the Opus plus immunoassay systemW R Sanhai, L F Romero, G Hickey, et al.
Clinical Biochemistry|April 29, 1998
Multicenter evaluation of the Abbott AxSYM procainamide and N-acetylprocainamide assays: comparison with Abbott TDx/TDxFLx, Syva EMIT 2000, DuPont ACA, and HPLC methodsH M Azzazy, P P Chou, A Poklis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 23, 2000
Characteristics of myoglobin, carbonic anhydrase III and the myoglobin/carbonic anhydrase III ratio in trauma, exercise, and myocardial infarction patientsJ R Beuerle, H M Azzazy, G Styba, et al.
Clinical Chemistry|June 1, 1983
Interpretation of cerebrospinal fluid protein assays in various neurologic diseasesR H Christenson, P Behlmer, J F Howard, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromesM Panteghini, F S Apple, R H Christenson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assaysF Dati, M Panteghini, F S Apple, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 26, 1982
A routine method for the determination of digoxin in urine by radioimmunoassayR H Christenson, J E Hammond, J H Hull, et al.
Hybridoma|January 16, 1999
Production and characterization of monoclonal antibodies to human carbonic anhydrase IIIH M Azzazy, P J Cummings, D R Ambrozak, et al.
Archives of Pathology & Laboratory Medicine|December 11, 1991
Improving the reliability of total and high-density lipoprotein cholesterol measurements. Four testing strategies compared in a high-risk populationR H Christenson, J R Roeback, T E Watson, et al.
Clinical Chemistry|April 1, 1987
Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxinR H Christenson, S D Studenberg, S Beck-Davis, et al.
Clinical Biochemistry|December 12, 2001
Performance characteristics of a revised cardiac Troponin I assay for the Opus plus immunoassay systemW R Sanhai, L F Romero, G Hickey, et al.
Clinical Biochemistry|April 29, 1998
Multicenter evaluation of the Abbott AxSYM procainamide and N-acetylprocainamide assays: comparison with Abbott TDx/TDxFLx, Syva EMIT 2000, DuPont ACA, and HPLC methodsH M Azzazy, P P Chou, A Poklis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 23, 2000
Characteristics of myoglobin, carbonic anhydrase III and the myoglobin/carbonic anhydrase III ratio in trauma, exercise, and myocardial infarction patientsJ R Beuerle, H M Azzazy, G Styba, et al.
Clinical Chemistry|June 1, 1983
Interpretation of cerebrospinal fluid protein assays in various neurologic diseasesR H Christenson, P Behlmer, J F Howard, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromesM Panteghini, F S Apple, R H Christenson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 2, 1999
Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assaysF Dati, M Panteghini, F S Apple, et al.
Pageof 9